Administering Intradermal, Subcutaneous, and Intramuscular Injections

Intradermal. This route involves administering medication directly into the dermis, the layer of skin just beneath the epidermis, allowing for localized effects and a slower absorption rate compared to other methods. A: Intra-articular. This method targets joints for direct medication delivery, bypassing the skin layers entirely and not suitable for upper skin layer injections. C: Subcutaneous. This route involves injecting drugs into the fatty tissue beneath the skin rather than directly into the skin layers themselves, resulting in different absorption characteristics. D: Intramuscular. This technique delivers medication into muscle tissue, which is deeper than the upper skin layers, leading to a faster absorption rate compared to intradermal administration.

D: Abdomen. The abdomen is recognized for its superior blood supply, leading to increased insulin absorption rates compared to other subcutaneous sites. Its central location facilitates quicker distribution into the bloodstream, making it ideal for rapid metabolic responses. A: Vastus lateralis. This site is associated with slower absorption rates due to less vascularity compared to the abdomen, impacting the speed of insulin entry into circulation. B: Dorsogluteal site. The dorsogluteal region has a lower blood supply, which leads to delayed absorption of insulin, making it less efficient for rapid glucose control. C: Back of upper arm. While usable, the back of the upper arm provides slower absorption than the abdomen due to reduced blood flow and subcutaneous fat distribution. E: Deltoid. The deltoid area has limited blood supply compared to the abdomen, resulting in slower insulin absorption and a less effective site for rapid action.

B: When mixing insulins, remember 'clear before cloudy' is essential for safe and effective administration. This guideline ensures that the rapid-acting or short-acting insulin is drawn first, preventing contamination and maintaining the effectiveness of both insulins during administration. A: Always withdraw intermediate-acting insulin first contradicts established protocols, as rapid-acting insulins should be drawn first to avoid contamination and ensure proper dosing for optimal patient management. C: Inject with 20-G, 1-inch needle may not be suitable for all patients, especially those requiring a finer gauge or different length for optimal subcutaneous absorption and comfort during insulin administration. E: Mix Lantus with regular insulin is not advisable, as Lantus is a long-acting insulin that should not be combined with other insulins, as this compromises its intended action and effectiveness.

Snap off the ampule neck using a sterile gauze pad. This step prevents injury from glass shards and maintains sterility while preparing the medication, ensuring safe and effective administration. D: Avoid tapping the top of the bottle. Tapping is irrelevant to ampule handling; it pertains to vial preparation and does not apply to the ampule's opening technique. B: Hold the ampule away from the body when breaking. Though important for safety, this step is not a primary action in the context of drawing medication from an ampule. C: Tilt the ampule and place the injection needle into the liquid. While this method may seem logical, it can lead to contamination or air bubbles if not executed properly. E: Use a filter needle to draw up medication. Filter needles are designed for drawing from vials and are unnecessary for ampules, where the glass shards are avoided by proper opening techniques.

A 22 G, 1½ inch needle is suitable for administering an IM injection of a nonviscous medication in the ventrogluteal site for a healthy adult male. The 22 G gauge provides an appropriate balance between flow rate and tissue damage, while the 1½ inch length ensures proper penetration into the muscle. This combination effectively delivers medication into the ventrogluteal site with minimal discomfort. A: 25 G, 1 inch This option offers a finer gauge but may impede medication flow, while the length is insufficient for deep muscle penetration in the ventrogluteal region. B: 18 G, 1½ inch Although this gauge allows for rapid administration, it is overly large for nonviscous medications and may cause unnecessary trauma to the tissue. D: 24 G, 2 inch While the length is adequate, the gauge is too fine for effective IM delivery, risking inadequate medication administration in the ventrogluteal site. E: 20 G, 1 inch The gauge is appropriate, but the length is inadequate for proper muscle depth, potentially compromising the injection efficacy in the ventrogluteal area.

A: Tuberculin syringe with 27-G, ??-inch needle. This option is appropriate because a tuberculin syringe is specifically designed for administering P.P.D. tests, ensuring precision in dosing and optimal penetration for accurate results. B: 1-mL syringe with 20-G, 1›-inch needle. The gauge and length are too large for a standard P.P.D., which requires a smaller gauge for accurate intradermal injection. C: Insulin syringe with 25-G, ??-inch needle. Insulin syringes are not suitable for P.P.D. testing; they lack the necessary precision and design for intradermal injections required in tuberculosis screening. D: 3-mL syringe with 25-G, ›-inch needle. A 3-mL syringe is excessive for a P.P.D. test, which only requires a small volume and accurate delivery through a specialized syringe. E: 1-mL syringe with 18-G, 1-inch needle. An 18-G needle is too thick for P.P.D. administration, which necessitates a finer gauge needle to minimize tissue damage and ensure accurate placement.

Intradermal tuberculosis tests should avoid aspiration before injecting the medication. This technique ensures a precise delivery of the antigen into the dermis without the risk of altering the test results or causing unnecessary discomfort. A: IM injection of antibiotics Aspiration is often performed to check for blood return, ensuring safety during intramuscular injections and preventing inadvertent vascular administration of the medication. D: IM pain medication Similar to antibiotics, aspirating helps confirm that the needle is not in a blood vessel, thus safeguarding against potential complications from intravenous administration.

The anatomical landmarks for the ventrogluteal site are the iliac crest, greater trochanter, and anterior superior iliac spine. These landmarks provide a safe and precise location for intramuscular injections, minimizing the risk of injury to surrounding nerves and blood vessels. C: Acromion process This landmark pertains to the shoulder region, which has no relevance to the ventrogluteal site, focusing instead on the upper limb anatomy. D: Coccyx Situated at the base of the spine, the coccyx does not relate to the ventrogluteal area, which is located in the hip region.

A: Give the medication all at once. Administering the insulin bolus all at once is appropriate for quickly managing hyperglycemia, especially with a glucose reading of 310 mg/dL in a patient with type I diabetes. B: Give the medication before meals. This option suggests a timing that is typically for long-acting or mealtime insulin, which does not apply to an urgent bolus for high glucose levels. C: Give the medication after meals. Administering insulin after meals delays the action needed to address hyperglycemia and could lead to further complications for the patient’s blood glucose control. D: Give the medication before and after meals and at bedtime. This approach involves multiple administrations, which is unnecessary in the case of a single urgent bolus required for a high glucose level.